Key Dates

Related Announcements

• July 12, 2023: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-23-230 
• July 12, 2023: PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed PA-23-232 
• March 22, 2023: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed) of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) PAR-23-138 
• January 20, 2023: Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) PA-23-080
• September 15, 2022: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)  RFA-NS-23-006
• September 15, 2022: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) RFA-NS-23-007 

Issued by

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

Purpose

This Notice informs potential applicants to the Notice of Funding Opportunities (NOFOs) listed below of a change to ORIP’s categorization under the Components of Participating Organizations section. ORIP was previously signed on under the subheading. “All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.” This notice corrects ORIP’s listing to be in the main “Components of Participating Organizations” section.

PA-23-080 Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35), 
PA-23-230 PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed), 
PA-23-232 PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed),
PAR-23-138 Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed), 
RFA-NS-23-006 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed), and
RFA-NS-23-007 HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed).

The following changes have been made to the above reference NOFOs

Currently Reads: 

Part 1. Overview Information

Components of Participating Organizations

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

Modified to Read:

Part 1. Overview Information

Components of Participating Organizations

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

No other changes to components of participating organizations have been made.

Inquiries

Please direct all inquiries to:

ORIP The Scientific Contact listed on the Original Notice of Funding Opportunity:

Training Awards (T35)
Ritesh Tandon, Ph.D.
Phone: 301-594-5304
Email: [email protected]

Small Business Programs SBIR and STTR (R43/44) and (R41/42)

Miguel Contreras, Ph.D.
Phone: 301-594-4927
Email: [email protected]

S10 Instrumentation Programs

Xiang-Ning Li, Ph.D.
Office of Research Infrastructure Programs (ORIP)
Phone: 301-435-1744
E-mail: [email protected]